Talis Biomedical Corp (TLIS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 0 | 73 | 195 | 140 | 581 |
| Cost of Goods | N/A | 6 | 8 | 6 | 7 |
| Gross Profit | N/A | 67 | 187 | 134 | 574 |
| Operating Expenses | 9,578 | 14,190 | 14,651 | 17,111 | 16,972 |
| Operating Income | -9,578 | -14,117 | -14,456 | -16,971 | -16,391 |
| Other Income | 729 | 1,082 | 996 | 1,289 | 1,357 |
| Pre-tax Income | -8,849 | -13,035 | -13,460 | -15,682 | -15,034 |
| Net Income Continuous | -8,849 | -13,035 | -13,460 | -15,682 | -15,034 |
| Net Income | $-8,849 | $-13,035 | $-13,460 | $-15,682 | $-15,034 |
| EPS Basic Total Ops | -4.86 | -7.15 | -7.39 | -8.62 | -8.27 |
| EPS Basic Continuous Ops | -4.86 | -7.15 | -7.39 | -8.62 | -8.27 |
| EPS Diluted Total Ops | -4.86 | -7.15 | -7.39 | -8.62 | -8.27 |
| EPS Diluted Continuous Ops | -4.86 | -7.15 | -7.39 | -8.62 | -8.27 |
| EPS Diluted Before Non-Recurring Items | -4.86 | -7.15 | -7.39 | -8.62 | -8.27 |
| EBITDA(a) | $-9,494 | $-13,855 | $-14,245 | $-16,754 | $-16,223 |